Clover Health Investments Crop. ($CLOV) Stock Forecast: Up 5.0% Today

What is Clover Health Investments Crop.?

Clover Health (CLOV) is a healthcare technology company that provides Medicare Advantage plans. The stock experienced a strong upward movement in today's market.

Why is Clover Health Investments Crop. going up?

CLOV stock is up 5.0% on May 19, 2026 17:15

• The interim CFO of Clover Health, Joseph Clay, had a portion of his RSUs withheld for tax obligations, suggesting positive sentiments about the company's future outlook.
• Fidelity Investments' SEC filing to sell a significant number of shares had a neutral impact on the market, indicating that this action might not be perceived negatively by market participants.
• Despite CEO Brady Patrick Priest selling a substantial amount of shares, analysts continue to forecast profitability for the company this year, potentially bolstering investor confidence.
• The CEO's insider selling of shares, though initially causing some negativity, did not deter investors, potentially highlighting a focus on the company's growth prospects.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

RSU vesting leads Clover Health (CLOV) interim CFO to tax share withholding

Clover Health's interim CFO, Joseph Clay, had 16,942 Class A shares automatically withheld at $3.47 per share on May 16, 2026, to cover tax obligations from RSU vesting. This tax withholding represents 6.25% of his original RSU grant from February 2024, with remaining RSUs vesting quarterly until February 2028, subject to continued service. Following this transaction, Clay directly holds 1,217,584 Class A shares.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-4b464d7ea665.html

[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing

This article details a Form 144 SEC filing by Clover Health Investments, Corp. (CLOV) concerning the proposed sale of 886,341 shares of Class A common stock by Fidelity Investments, acquired through a stock plan option on April 29, 2025. The filing indicates a neutral impact and sentiment, with an aggregate market value of over $3 million for the shares to be sold.

https://www.stocktitan.net/sec-filings/CLOV/144-clover-health-investments-corp-de-sec-filing-5495c3a328ff.html

Clover Health CEO Brady Priest sells $345,097 in shares By Investing.com

Brady Patrick Priest, CEO of Clover Care Services, a subsidiary of Clover Health Investments Corp., sold 98,039 shares of Class A Common Stock for $345,097. Following this transaction, Mr. Priest still holds over 2 million shares. Despite analysts predicting profitability this year, InvestingPro analysis suggests CLOV is currently slightly overvalued.

https://in.investing.com/news/insider-trading-news/clover-health-ceo-brady-priest-sells-345097-in-shares-93CH-5404889

Clover Health CEO Brady Priest sells $345,097 in shares By Investing.com

Brady Patrick Priest, CEO of Clover Care Services (a subsidiary of Clover Health Investments Corp.), sold 98,039 shares of Class A Common Stock for a total of $345,097 on May 13, 2026. This transaction leaves him with 2,040,222 shares. Despite the company appearing slightly overvalued, analysts are predicting profitability for the current year.

https://ng.investing.com/news/insider-trading-news/clover-health-ceo-brady-priest-sells-345097-in-shares-93CH-2508119

[Form 4] CLOVER HEALTH INVESTMENTS, CORP. /DE Insider Trading Activity

Brady Patrick Priest, CEO of Clover Care Services, a subsidiary of Clover Health Investments, Corp. (CLOV), reported an open-market sale of 98,039 shares of Class A common stock at $3.52 per share on May 13, 2026. After this transaction, Priest directly holds 2,040,222 shares. This Form 4 filing indicates a moderate impact with a negative sentiment due to the insider selling shares.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-9985e975f67f.html

Trending Today

Cadence Design Systems Inc. ($CDNS) Stock Forecast: Up 5.0% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Up 6.0% Today

Texas Instruments Incorporated ($TXN) Stock Forecast: Up 5.1% Today

Estee Lauder Companies Inc. (The) ($EL) Stock Forecast: Up 10.6% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 8.1% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Up 11.3% Today

Ross Stores Inc. ($ROST) Stock Forecast: Up 6.9% Today

Corsair Gaming Inc. ($CRSR) Stock Forecast: Up 9.8% Today

Skyworks Solutions Inc. ($SWKS) Stock Forecast: Up 9.3% Today

Cencora Inc. ($COR) Stock Forecast: Up 5.1% Today

Clover Health Investments Crop. Price History

22.03.2026 - CLOV Stock was up 5.2%

• The positive sentiment surrounding CLOV stock today may be linked to executives having shares withheld for tax obligations related to the vesting of restricted stock units (RSUs), signaling confidence in the company's future growth.
• Tax-related share withholding actions by top executives, including the CEO, CFO, and Chief Legal Officer, may have bolstered investor trust in the leadership team's dedication to long-term success, boosting investor confidence and elevating the stock price.
• These transactions reflect transparency and adherence to tax regulations, potentially boosting the company's reputation and credibility with investors and stakeholders, fueling the bullish market movement in CLOV stock today.

19.04.2026 - CLOV Stock was up 5.0%

• The interim CFO of Clover Health, Joseph Clay, had a portion of his RSUs withheld for tax obligations, suggesting positive sentiments about the company's future outlook.
• Fidelity Investments' SEC filing to sell a significant number of shares had a neutral impact on the market, indicating that this action might not be perceived negatively by market participants.
• Despite CEO Brady Patrick Priest selling a substantial amount of shares, analysts continue to forecast profitability for the company this year, potentially bolstering investor confidence.
• The CEO's insider selling of shares, though initially causing some negativity, did not deter investors, potentially highlighting a focus on the company's growth prospects.

02.03.2026 - CLOV Stock was up 6.0%

• The rise in CLOV stock today could be linked to the announcement of an upcoming CFO transition. Despite this change, the company reiterated its financial outlook for 2026, which likely boosted investor confidence in its strategy and financial health.
• Although Vanguard reported holding zero shares in Clover Health, causing initial concerns, the market sentiment appeared to shift positively due to the company's reaffirmed financial guidance and growth prospects.
• An AI Analyst rated CLOV stock as Neutral citing a mix of financial quality and technical pressures, which may have dampened some market enthusiasm. However, the focus on membership growth and profitability goals likely balanced this, contributing to the observed bullish trend.

21.03.2026 - CLOV Stock was up 10.2%

• The bullish movement in CLOV's stock today is possibly influenced by executives' decision to withhold shares for tax obligations relating to the vesting of restricted stock units (RSUs), showcasing confidence in the company's future performance.
• Routine tax-related dispositions by key executives, including the CEO, CFO, and Chief Legal Officer, reflect their dedication to Clover Health's long-term success, likely bolstering investor confidence.
• These transactions could be seen as a positive display of transparency and sound financial management, potentially contributing to the upward momentum in CLOV's stock price.
• Overall, the market's favorable reaction to the executives' actions hints at their trust in Clover Health's growth potential and financial stability.

18.02.2026 - CLOV Stock was down 5.1%

• Executives at Clover Health, including Jamie L. Reynoso and Conrad Wai, had shares withheld to cover tax obligations related to vested restricted stock units (RSUs).
• The automatic withholding of shares for tax purposes may have led to increased selling pressure on the stock, contributing to the bearish movement.
• Investors might interpret the executives' actions as a lack of confidence in the company's future performance, further dampening market sentiment towards Clover Health.
• The series of tax-related share withholdings could have signaled potential concerns about the company's financial health or regulatory challenges, prompting investors to react bearishly.

15.04.2026 - CLOV Stock was down 5.3%

• The decrease in CLOV's stock price could be linked to the CEO, Brady Patrick Priest, selling a considerable number of shares, potentially indicating uncertainties or lacking confidence within the company.
• Furthermore, the insider selling disclosed in Form 4 filings by both CEO Brady Patrick Priest and CEO Andrew Toy may have triggered concerns among investors, resulting in diminished market trust and a subsequent drop in the stock value.
• Despite analysts forecasting profitability for the ongoing year, the stock's perception of being slightly overvalued, as highlighted in InvestingPro's analysis, might have also played a role in fostering negative sentiment and downward pressure on CLOV's shares.

06.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV stock could be attributed to the positive sentiment generated by executives receiving significant RSU grants, indicating confidence in the company's future performance and growth prospects.
• The announcement of the CFO transition and the reaffirmation of the 2026 financial outlook might have also contributed to investor optimism, showcasing stability and strategic planning within the company.
• The consistent vesting schedule of RSUs for key executives like Brady Patrick Priest, Karen Soares, Jamie L. Reynoso, and Wai Conrad, highlights a long-term commitment to the company's success, instilling trust among shareholders and potential investors.
• Overall, these developments suggest a positive outlook for Clover Health, reinforcing investor confidence and driving the bullish movement in CLOV stock.

07.04.2026 - CLOV Stock was up 5.8%

• The bullish movement in CLOV could be attributed to investors gaining confidence in the company's ability to navigate through the ongoing securities class action lawsuit.
• Despite the legal challenges, the market seems to be optimistic about Clover Health's future prospects and potential for growth in the healthcare technology sector.
• Investors might be reassured by the company's response to the allegations and its efforts to address any concerns raised by the Department of Justice investigation and related-party deals.
• The upcoming deadline for the lead plaintiff in the securities class action lawsuit could also be driving increased interest and trading activity in CLOV as investors position themselves based on potential outcomes.

24.02.2026 - CLOV Stock was down 6.5%

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

13.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV's stock could be attributed to the positive sentiment generated by recent filings of beneficial ownership by key executives, including the VP of Finance, interim CFO, and CEO of Medicare Advantage.
• Disclosure of significant share ownership and RSUs by these executives indicates their confidence in the company's future performance, likely appealing to investors.
• The CEO of Medicare Advantage using vested shares to cover tax obligations demonstrates commitment to long-term growth, which could enhance investor trust and optimism in CLOV's prospects.
• The various ownership disclosures and transactions by key executives at Clover Health Investments probably played a role in today's bullish movement in CLOV's stock.

13.04.2026 - CLOV Stock was up 5.3%

• A tax-related share withholding transaction took place on May 8, 2026, where CEO Andrew Toy withheld 85,704 shares to meet tax obligations. This action might have suggested a positive outlook on the company's future.
• The scheduled quarterly vesting of remaining restricted stock units (RSUs) until August 8, 2026, could have instilled confidence among investors, signaling a strong commitment from the leadership.
• The insider activity, including the aforementioned transactions, likely bolstered shareholder confidence and drew in new investors, influencing CLOV's stock price surge today.

14.04.2026 - CLOV Stock was up 7.5%

• The bullish movement in CLOV's stock price today may have been influenced by CEO Brady Patrick Priest's sale of shares, which could have boosted investor confidence in the company's future.
• Analysts' positive predictions of profitability for the current year might have contributed to the upward trend in CLOV's stock price, despite concerns about its valuation.
• The recent insider selling of shares by CEO Priest, disclosed in a Form 4 filing, initially raised concerns of insider trading but the market focus appears to have shifted towards the company's positive outlook.
• CEO Andrew Toy's routine share withholding transaction for tax purposes did not seem to have a significant impact on CLOV's market performance today, with investors likely more swayed by profitability forecasts and CEO Priest's share sale.